Tamar Thompson is a government affairs and health policy strategist with more than 20 years of leadership experience. Tamar also has extensive market access experience; over the course of her career she has worked with governmental agencies, private payers, Congressional leaders, and patient advocacy groups to ensure optimal patient access to existing and new medical therapies, including rare disease. Prior to joining Alexion, Tamar lead Federal Exeuctive Branch Strategy and State Government Affairs for Bristol-Myers Squibb Company, Mrs. Thompson served a strategic policy advisor and consultant for three premiere Washington DC based firms, ADVI, Kimbell & Associates and Avalere Health, where she managed a diverse portfolio of clients, including medical device, biotech, pharmaceutical, and specialty drug, companies. Preceding her time in Washington DC, Ms. Thompson was Director of Health Policy & Reimbursement at Molecular Insight Pharmaceuticals (MIP) where she was charged with developing and launching reimbursement strategy for cutting-edge molecular diagnostic and therapeutic treatments options. She has also held health policy and reimbursement leadership strategy roles at GE Healthcare and Bracco Diagnostics. Tamar has also served as claims operations director and benefit plan manager in the managed care sector for Humana and ValueOptions. Tamar also serves on the board of directors for MassBio, Healthy Women, and the University of Richmond Customer Experience Advisory Board. Tamar holds a M.S. in Health Sciences with a concentration in Public Health from Trident University in Cypress California. She also has an Executive Leadership certificate from Columbia University and maintains active certifications from the American Health Information Management Association (AHIMA) as a Certified Coding Specialist (CCS) and Certified Coding Specialist – Physician Based (CCS-P).